TYROSINE KINASE INHIBITORS AND INTERFERON
The use of interferon-a (INF) in chronic myeloid leukemia, when it started in the 80s, was considered as a breakthrough in the therapy of this disease; INF administered alone or in combination with aracytine was the standard choice for treatment for Chronic Myeloid Leukemia (CML) patients unfi...
Sábháilte in:
| Príomhchruthaitheoirí: | , |
|---|---|
| Formáid: | Artigo |
| Teanga: | Inglês |
| Foilsithe / Cruthaithe: |
PAGEPress Publications
2014-01-01
|
| Sraith: | Mediterranean Journal of Hematology and Infectious Diseases |
| Ábhair: | |
| Rochtain ar líne: | http://www.mjhid.org/index.php/mjhid/article/view/1359 |
| Clibeanna: |
Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!
|